Akcea Therapeutics Inc. (AKCA)

Trade AKCA now with
3/15/2018 6:53:01 AM Ionis And Akcea Collaborate To Commercialize Inotersen For HATTR
2/27/2018 7:07:40 AM Ionis Pharma Q4 Revenue $172 Mln Vs $160 Mln Last Year
2/20/2018 7:05:19 AM Ionis Pharma Licences New Antisense Drug For Kidney Disease To AstraZeneca
2/7/2018 7:08:11 AM Akcea Therapeutics Completes Enrollment In Phase 2b Study Of AKCEA-APO(a)-LRx
12/14/2017 7:12:21 AM Akcea Therapeutics Begins Phase 2 Study Of AKCEA-ANGPTL3-LRx
11/15/2017 7:07:05 AM Akcea, Ionis Announce Acceptance Of Marketing Applications In U.S., EU And Canada For Volanesorsen
9/6/2017 7:20:47 AM Akcea Therapeutics Establishes Canadian Subsidiary; Appoints Jared Rhines As Canadian General Manager
8/31/2017 7:05:08 AM Akcea Therapeutics, Ionis Pharma Say Submits NDA For Volanesorsen To The US FDA